The acquired immunodeficiency syndrome (AIDS) is a global pandemic with over 13 million human immunodeficiency virus (HIV)-infected individuals worldwide. A major focus within our laboratory has been on defining the unique epidemiologic, clinical, virologic and immunologic features of HIV-1 and HIV-2 infections in developing countries and in the U.S. In Zaire we demonstrated a 40% infection rate in female prostitutes with an estimated 10% annual seroincidence. In India we documented a rise in HIV infection among prostitutes from 7.3% to 38.6% and from 1% to 15% among STD clinic attendees over the past 3 years. Among patients attending STD clinics in Baltimore, a retrospective 10-year survey demonstrated a marked increase in HIV infection from 0.2 to 5.5%. Common to all three cohorts was the strong association of HIV infection among heterosexuals with recent genital ulcerative and non-ulcerative sexually transmitted diseases. Even among patients attending a U.S. inner-city emergency department, HIV infection increased from 6.0% to 11.3% over 4 years with a marked increase among young women, black males, and heterosexuals. In perinatal studies of over 500 children born to HIV-infected women, we documented a 28% perinatal transmission rate which correlated with depressed maternal CD4+ and elevated CD8+ lymphocyte counts, anemia, chorioamnionitis and funisitis. There was no association between the presence of neutralizing antibodies of the V3 loop of gp120 and perinatal transmission. We developed an algorithm utilizing two serologic assays, the immune complex dissociated-p24 antigen assay and the IgA assay, which could reliably diagnose perinatal infection after the first week of life with a sensitivity and specificity of 99%, respectively. In two separate cohorts in Brazil and Haiti, we documented that human T lymphotrophic virus type 1 (HTLV-1) infection may accelerate the clinical course of HIV infection despite modulating the increase in nonfunctional CD4+ lymphocytes. Additional studies are planned to further elucidate the immunologic modulation of HIV infection by co-infection with HTLV-1 infection in these cohorts.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Intramural Research (Z01)
Project #
1Z01AI000361-11
Application #
3768782
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
11
Fiscal Year
1993
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
Meya, David; Spacek, Lisa A; Tibenderana, Hilda et al. (2009) Development and evaluation of a clinical algorithm to monitor patients on antiretrovirals in resource-limited settings using adherence, clinical and CD4 cell count criteria. J Int AIDS Soc 12:3
Johnson, Kristine E; Quinn, Thomas C (2008) Update on male circumcision: prevention success and challenges ahead. Curr Infect Dis Rep 10:243-51
Blake, Diane R; Maldeis, Nancy; Barnes, Mathilda R et al. (2008) Cost-effectiveness of screening strategies for Chlamydia trachomatis using cervical swabs, urine, and self-obtained vaginal swabs in a sexually transmitted disease clinic setting. Sex Transm Dis 35:649-55
Chang, Larry William; Kagaayi, Joseph; Nakigozi, Gertrude et al. (2008) Telecommunications and health Care: an HIV/AIDS warmline for communication and consultation in Rakai, Uganda. J Int Assoc Physicians AIDS Care (Chic) 7:130-2
Blake, Diane R; Quinn, Thomas C; Gaydos, Charlotte A (2008) Should asymptomatic men be included in chlamydia screening programs? Cost-effectiveness of chlamydia screening among male and female entrants to a national job training program. Sex Transm Dis 35:91-101
NIMH Collaborative HIV/STD Prevention Trial Group (2007) Design and integration of ethnography within an international behavior change HIV/sexually transmitted disease prevention trial. AIDS 21 Suppl 2:S37-48
NIMH Collaborative HIV/STD Prevention Trial Group (2007) The feasibility of audio computer-assisted self-interviewing in international settings. AIDS 21 Suppl 2:S49-58
NIMH Collaborative HIV/STD Prevention Trial Group (2007) Selection of populations represented in the NIMH Collaborative HIV/STD Prevention Trial. AIDS 21 Suppl 2:S19-28
NIMH Collaborative HIV/STD Prevention Trial Group (2007) Methodological overview of a five-country community-level HIV/sexually transmitted disease prevention trial. AIDS 21 Suppl 2:S3-18
Waters, Laura; Kambugu, Andrew; Tibenderana, Hilda et al. (2007) Evaluation of filter paper transfer of whole-blood and plasma samples for quantifying HIV RNA in subjects on antiretroviral therapy in Uganda. J Acquir Immune Defic Syndr 46:590-3

Showing the most recent 10 out of 123 publications